Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

NEXT STORY
Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases
PREV STORY
Global Atopic Eczema Treatment Market Will Reach USD 34,089.3 Million by 2026: Facts & Factors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered Products

Key Clinical Portfolio Development Progress Planned for 2018              Tedopi® (neoepitopes): Phase 3 clinical trial in ...

author_avatar
NASDAQ Market News

OCREVUS (ocrelizumab) data show early initiation of treatment reduces disability progression over five years in relapsing and primary progressive multiple sclerosis

People with relapsing MS (RMS) treated sooner with OCREVUS had earlier reduction in disease ...

author_avatar
NASDAQ Market News

Basilea reports strong, higher than expected preliminary revenue of CHF 133 million for financial year 2018

Basel, Switzerland, January 07, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the ...

author_avatar
NASDAQ Market News